LSI Asia 2025

Event Overview

Life Science Intelligence (LSI), a leading MedTech market intelligence firm, launched its inaugural Asian summit in Singapore in 2025, providing a platform for innovators to connect with capital, strategic partners and expertise.

LSI Asia 2025 marked a pivotal expansion of LSI’s mission to support innovators to scale globally, amid Asia Pacific’s emergence as a global MedTech hub. It is LSI’s 10th summit and the third in its global Emerging MedTech Summit series, after establishing events in the US and Europe.

Held from 10–13 June 2025 at The Ritz-Carlton, Millenia Singapore, LSI Asia drew more than 400 attendees from across the world, including innovators, investors, strategic corporate players, senior leaders and partners from global MedTech and healthcare industries. They had convened for meaningful engagements on next-generation technologies like artificial intelligence-powered diagnostics, robotics, advanced imaging and digital therapeutics.

Countries like Singapore, China, South Korea, and India are also leading in surgical volume growth and attracting significant venture and strategic investment.

According to Pantel, Singapore was chosen as a host city for the inaugural Asia event because of its advanced research and development capabilities, world-class MedTech infrastructure, and its commercial-stage, globally competitive technologies. The city also boasts of a robust regulatory framework and a supportive government, as well as a vibrant investment landscape with prominent institutional investors, he said.

“Singapore is a natural choice for us to bring our event because of its location. And it's a country with a long history of innovation. In our view, this is the opportunity for the East to meet West and to really grow the medical device industry by doing cross border deals, cross border partnering, and launching this industry into the future.”

“The panel sessions featured Asian top leaders and MedTech companies. It's a whole new perspective and a whole new set of people that I would not ordinarily run into,” said Lloyd Mencinger, President & CEO of Aqua Medical, a startup.

Attending the event, Mencinger said, allowed him to meet his business objective – connecting with potential investors. He also noted that attendees from the region were drawn to the event and Singapore because of the “vibrant [MedTech] community and ecosystem”.

In addition, the city’s top-notch conference venues and facilities aligned with LSI’s commitment to high-impact, in-person collaboration and networking.

Eduardo Fonseca, CEO of XCath, described LSI as a vital connector for the industry.

“LSI has always been a fantastic platform for MedTech. It's a place for meeting and gathering. And I'm very happy that the first edition in Asia is here.

He added that Singapore’s strategic position makes it ideal for growth.

“Singapore is one of the major gateways to Asia. It has a network of partners that operate across the region, so it's incredibly convenient to do business in one place and look at potential distributors, partners, technology partners that could potentially down the road help commercialise technologies like ours. There are a lot of key opinion leaders that operate out of Singapore and have a lot of influence in the region,” Fonseca said.